105 results
Page 3 of 6
424B5
qson2ie79mf8 1t2
11 Aug 21
Prospectus supplement for primary offering
6:56am
8-K
EX-99.1
mw6ft0ybx0t3v
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
7oze3uayl
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
oeni1ds
26 Jul 21
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Executive Officer
4:18pm
424B3
4h38orx
30 Apr 21
Prospectus supplement
5:01pm
8-K/A
EX-99.1
5gw9xo
5 Mar 21
Financial Statements and Exhibits
4:15pm
8-K/A
EX-99.3
u2b6b6 sy
5 Mar 21
Financial Statements and Exhibits
4:15pm
8-K
EX-10.1
3so8txycf80df n0o5kh
1 Feb 21
Departure of Directors or Certain Officers
6:55am